These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35146503)

  • 21. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
    Curhan GC; Willett WC; Speizer FE; Stampfer MJ
    Kidney Int; 2001 Jun; 59(6):2290-8. PubMed ID: 11380833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Questionable significance of the chemical analysis of a single 24-hour urine sample in recurrent calcium oxalate nephrolithiasis].
    Riess C; Hess B; Binswanger U
    Klin Wochenschr; 1986 May; 64(9):411-6. PubMed ID: 3713110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urine composition following jejunoileal bypass.
    Nordenvall B; Backman L; Larsson L; Tiselius HG
    Eur Urol; 1983; 9(1):35-9. PubMed ID: 6822241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The loss of circadian rhythmicity of urinary solute excretion in idiopathic stone formers.
    Sidhu H; Vaidyanathan S; Wangoo D; Thind SK; Nath R; Malakondaiah GC; Krishan K
    Br J Urol; 1989 Oct; 64(4):333-5. PubMed ID: 2819381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum and 24-hour urinary tests cost-effectiveness in stone formers.
    Mohammadi A; Farabi H; Baghdadabad LZ; Narouie B; Reis LO; Aghamir SMK
    BMC Urol; 2023 Aug; 23(1):141. PubMed ID: 37635222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Idiopathic calcium nephrolithiasis. 2. Differences between hypercalciuric and normocalciuric persons with recurrent kidney stone formation and persons without such a history.
    Wilson DR; Pylypchuk G; Ehrig U
    Can Med Assoc J; 1979 Mar; 120(6):666-9. PubMed ID: 436048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of lithogenic elements in urine of healthy newborns.
    Cillo AC; Cattini H; Boim MA; Schor N
    Pediatr Nephrol; 2001 Dec; 16(12):1080-3. PubMed ID: 11793105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary factors of kidney stone formation in patients with Crohn's disease.
    Böhles H; Beifuss OJ; Brandl U; Pichl J; Akçetin Z; Demling L
    Klin Wochenschr; 1988 Feb; 66(3):87-91. PubMed ID: 3352194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
    Negri AL; Spivacow FR; Del Valle EE; Forrester M; Rosende G; Pinduli I
    Urol Res; 2008 Dec; 36(6):303-7. PubMed ID: 18985334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy.
    Oehlschläger S; Albrecht S; Hakenberg OW; Schrödter S; Froehner M; Manseck A; Wirth MP
    Urology; 2003 Jul; 62(1):17-21. PubMed ID: 12837412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Circadian rhythms of lithogenic and inhibitory substances in the urine].
    Ebisuno S; Morimoto S; Yasukawa S; Yoshida T; Fukatani T; Minakata S; Uehara M; Ohkawa T
    Hinyokika Kiyo; 1986 May; 32(5):667-71. PubMed ID: 3751794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of phyllanthus niruri on metabolic parameters of patients with kidney stone: a perspective for disease prevention.
    Pucci ND; Marchini GS; Mazzucchi E; Reis ST; Srougi M; Evazian D; Nahas WC
    Int Braz J Urol; 2018; 44(4):758-764. PubMed ID: 29617079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiopathic calcium nephrolithiasis. 1. Differences in urine crystalloids, urine saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone formation.
    Pylypchuk G; Ehrig U; Wilson DR
    Can Med Assoc J; 1979 Mar; 120(6):658-65. PubMed ID: 436047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urine composition in patients with renal stone disease during treatment with allopurinol.
    Tiselius HG; Larsson L
    Scand J Urol Nephrol; 1980; 14(1):65-71. PubMed ID: 7375845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.